Literature DB >> 22231480

Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients.

Rebecca M Speck1, Angela DeMichele, John T Farrar, Sean Hennessy, Jun J Mao, Margaret G Stineman, Frances K Barg.   

Abstract

PURPOSE: This study explored the self-management strategies utilized by female breast cancer patients to cope with the impact of chemotherapy-induced peripheral neuropathy (CIPN) symptoms. We also examined the variety of taxane-related side effects in women with and without CIPN in order to discriminate the CIPN symptom experience.
METHODS: A purposive sample of 25 patients treated with docetaxel or paclitaxel were recruited, half with and half without CIPN. Semistructured interviews and patient level data were utilized for this exploratory, descriptive study. Interview data were analyzed with the constant comparative method; patient level data were abstracted from the electronic medical record.
RESULTS: Participants were aged 24-60 years, were currently receiving chemotherapy or within 6 months of having completed treatment, and 14 had CIPN. CIPN impacted routine activities, functions, and behaviors in the areas of domestic, work, and social/leisure life. Multiple self-management and coping strategies to minimize the impact of CIPN symptoms were reported; the focus was on movement to reduce symptoms, attitude awareness, logistics to simplify demands, and environmental change. Women with and without CIPN were similar in the quantity and type of other reported side effects.
CONCLUSIONS: CIPN affects breast cancer patients' routine activities, functions, and behaviors, but they develop management strategies to reduce the impact. The management strategies reported in this study suggest breast cancer patients may adopt interventions that focus on exercise, mindfulness, occupational therapy, and environmental planning toward the goal of reducing the impact of CIPN symptoms on their lives.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22231480     DOI: 10.1007/s00520-011-1365-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  24 in total

Review 1.  Complementary and alternative medicine in breast cancer patients.

Authors:  Zeina Nahleh; Imad A Tabbara
Journal:  Palliat Support Care       Date:  2003-09

2.  Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.

Authors:  Beth Dunlap; Judith A Paice
Journal:  J Support Oncol       Date:  2006-09

Review 3.  Managing treatment side effects in advanced breast cancer.

Authors:  Susan Moore
Journal:  Semin Oncol Nurs       Date:  2007-11       Impact factor: 2.315

Review 4.  Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.

Authors:  Sherry Wolf; Debra Barton; Lisa Kottschade; Axel Grothey; Charles Loprinzi
Journal:  Eur J Cancer       Date:  2008-06-18       Impact factor: 9.162

5.  Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.

Authors:  Michael J Hassett; A James O'Malley; Juliana R Pakes; Joseph P Newhouse; Craig C Earle
Journal:  J Natl Cancer Inst       Date:  2006-08-16       Impact factor: 13.506

Review 6.  Chemotherapy dose reduction and delay in clinical practice. evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer.

Authors:  J Chang
Journal:  Eur J Cancer       Date:  2000-04       Impact factor: 9.162

7.  A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer.

Authors:  Katsumasa Kuroi; Kojiro Shimozuma; Yasuo Ohashi; Ayano Takeuchi; Toshihiko Aranishi; Satoshi Morita; Shozo Ohsumi; Toru Watanabe; Stacey Bain; Frederick H Hausheer
Journal:  Jpn J Clin Oncol       Date:  2008-10-08       Impact factor: 3.019

Review 8.  Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report.

Authors:  Margaret Rothman; Laurie Burke; Pennifer Erickson; Nancy Kline Leidy; Donald L Patrick; Charles D Petrie
Journal:  Value Health       Date:  2009-09-25       Impact factor: 5.725

Review 9.  Pharmacogenomics of sex difference in chemotherapeutic toxicity.

Authors:  Jeffrey Wang; Ying Huang
Journal:  Curr Drug Discov Technol       Date:  2007-06

10.  Background noise: the experience of chemotherapy-induced peripheral neuropathy.

Authors:  Marie A Bakitas
Journal:  Nurs Res       Date:  2007 Sep-Oct       Impact factor: 2.381

View more
  23 in total

Review 1.  Therapeutic strategies for cancer treatment related peripheral neuropathies.

Authors:  Deirdre R Pachman; James C Watson; Charles L Loprinzi
Journal:  Curr Treat Options Oncol       Date:  2014-12

2.  Cold therapy to prevent paclitaxel-induced peripheral neuropathy.

Authors:  Claire Griffiths; Nancy Kwon; Jennifer L Beaumont; Judith A Paice
Journal:  Support Care Cancer       Date:  2018-04-21       Impact factor: 3.603

Review 3.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

Review 4.  Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review.

Authors:  Cloé Brami; Ting Bao; Gary Deng
Journal:  Crit Rev Oncol Hematol       Date:  2015-11-23       Impact factor: 6.312

5.  Taste alteration in breast cancer patients treated with taxane chemotherapy: experience, effect, and coping strategies.

Authors:  Rebecca M Speck; Angela DeMichele; John T Farrar; Sean Hennessy; Jun J Mao; Margaret G Stineman; Frances K Barg
Journal:  Support Care Cancer       Date:  2012-08-05       Impact factor: 3.603

6.  Predictive clinical factors of chronic peripheral neuropathy induced by oxaliplatin.

Authors:  Nilgun Yildirim; Mahir Cengiz
Journal:  Support Care Cancer       Date:  2020-01-23       Impact factor: 3.603

7.  Missed opportunities for physical activity management at key points throughout the chemotherapy pathway for colorectal survivors: an observational interview study.

Authors:  I Veal; N Peat; G D Jones; V Tsianakas; J Armes
Journal:  Support Care Cancer       Date:  2018-10-11       Impact factor: 3.603

8.  Hybrid Tele and In-Clinic Occupation Based Intervention to Improve Women's Daily Participation after Breast Cancer: A Pilot Randomized Controlled Trial.

Authors:  Khawla Loubani; Rachel Kizony; Uzi Milman; Naomi Schreuer
Journal:  Int J Environ Res Public Health       Date:  2021-06-02       Impact factor: 3.390

9.  The association of self-efficacy and health literacy to chemotherapy self-management behaviors and health service utilization.

Authors:  Janet Papadakos; Jan Barnsley; Whitney Berta; Gillian Rowlands; Diana Samoil; Doris Howell
Journal:  Support Care Cancer       Date:  2021-08-04       Impact factor: 3.603

10.  Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy.

Authors:  Hsing-Wei Hung; Chien-Ying Liu; Hsiu-Fang Chen; Chun-Chu Chang; Shu-Ching Chen
Journal:  Int J Environ Res Public Health       Date:  2021-05-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.